Trial intelligence / Profile preview

Noscapine for treatment of massive ischemic stroke

IRCT138809282886N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of noscapine in ischemic stroke, sponsored by Iran University of Medical Sciences. Started Apr 2008; status: completed.

02

Drugs

noscapine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT138809282886N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138809282886N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call